Novogene is working with Mission Bio to offer customers in China access to the Tapestri Platform, which is being used in the drug development process by LabCorp and more than a dozen institutions.
Drug development advisory firm Rosa & Co. enters research agreement with Chugai pharmaceutical to provide access to PhysioPD research services for translational biology.
Recipham has agreed to pay the founders of Nitin Lifescience Limited INR2.8bn ($44m) for the remaining 26% stake they own in the India-based drug manufacturer.
Following its proposed LabAnswer acquisition, Accenture will form a scientific informatics service division, which it said will enable new patient treatments with “new insights into human biology.”
Thermo Fisher Scientific says it is buying Finesse Solutions, its long-term supplier of measurement and control solutions for bioprocessing applications.
EAG Laboratories has added 33,000-square-feet to its Easton, Maryland facility, with space for dedicated laboratories and equipment to support GLP-compliant ecotoxicology, environmental fate, metabolism, and other testing services.
Lonza has increased its 2016 earnings guidance after strong H1 growth of its biologic APIs business.
Envigo has announced that its sites in Bresso, Italy and Wyton, UK have earned their accreditation from the lab animal treatment watchdog, AAALAC.
Thermo Fisher will expand its antibody, multiplex RNA, and protein analysis tech offerings through the $1.3bn acquisition of Affymetrix.
British CRO Concept Life Sciences has bought toxicology business CXR Biosciences, its fourth acquisition since it formed in July 2014.
Some drug industry sponsors shy away from “jack of all trades” contractors according to a recently formed UK CRO network which says smaller firms with specific expertise can win market share.
GE Healthcare has pledged its support and technology to a national £55m ($86m) Cell Therapy manufacturing centre in Stevenage, UK, set to launch in 2017.
Indian CRO GVK BIO announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment CRO operating out of Chennai, India.
Sanofi has agreed to sell a life sciences park it owns on in Paris, France to public investment group, Caisse de Depots (CDC).
Lonza has reorganised its operations into two new divisions – Pharma and Specialty ingredients – and says more changes are on the way.
Appointments at Sanofi, Amylin, Lophius Biosciences, Lophius, Adventrx, BioSante and Medicure – People on the move
in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, Amylin, Lophius Biosciences, Lophius, Adventrx, BioSante and Medicure.
Appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
Lonza using energy broker to cut costs at production sites
Lonza is working with energy broker Usource to reduce costs at a number of its US production and R&D facilities.
Bayer injects €35m in biologics project expansion
Bayer HealthCare is investing €35m ($47m) in a new centre for the biotechnological production of ‘innovative’ pharmaceuticals to be used in clinical trials.
Pfizer and AstraZeneca naming R&D leaders and appointments at APV and Lonza – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Pfizer and AstraZeneca naming R&D leaders and appointments at APV and Lonza.
Sigma’s Q1 helped by HPAPI sales
Demand for HPAPIs helped US life science and technology supplier Sigma-Aldrich to a positive set of first quarter financials.
Lonza reports stronger demand in Q1 but remains cautious
Lonza has reported stronger demand in the first quarter, but volatility remains in the custom manufacturing sector and it is uncertain if improvements “represent true and full economic recovery”.
Ricerca partners with LSP to target Asian market
Contract research organisation (CRO) Ricerca Biosciences has entered into a business development deal with Japan-based Life Science Partner (LSP) to help penetrate the Asian market.
Alpha acquires CRO to target Mass bio
Environmental laboratory Alpha Analytical has expanded into the life sciences sector by acquiring CRO Boston Analytical and is now targeting the Massachusetts, US biotech sector, its president told Outsourcing-Pharma.
Bright times for Puerto Rico as another delivery giant sets up
DHL Global Forwarding has opened a Life Science Competency Center in Carolina, Puerto Rico, which will offer shipping services tailored to the needs of the island’s biotech and pharmaceutical companies.
Novel method speeds up HTS imaging analysis
Scientists have uncovered a technique that significantly shortens
the automation time for a particular method that analyses cell
cultures and other biologically important specimens.
Certification supports BioDuro's global ambitions
US-based BioDuro and The National Center for Safety Evaluation of
Drugs (NCSED) in Beijing have received full accreditation from the
Association for Assessment and Accreditation of Laboratory Animal
Care International (AAALAC).
Draxis, Intertech Bio, Relypsa, Ikaria Holdings and BioReliance - People on the move
Draxis, Intertech Bio, Relypsa, Ikaria Holdings and BioReliance
have all had people on the move in the world of pharmaceutical
Affymetrix buys USB to accelerate genetic tools development
Microarray expert Affymetrix is to buy molecular biology reagent
firm USB Corporation for $75m (€52m) in a bid to accelerate the
development of new genetic analysis tools.
Preclinical services news in brief
In this week's review of activity within the preclinical research
services arena, new deals have emerged involving GVK Biosciences,
Lab Research, GATC Biotech and Bridge Pharmaceuticals.
GE's online life science shopping mall
GE Healthcare Life Sciences division has launched a free-of-charge
one-stop shop for all life science purchases, regardless of
supplier, to give customers greater control over the ordering
Preclinical services news in brief
In this week's review of activity within the preclinical research
services arena, new deals have emerged involving Gene Bridges,
Panacos Pharmaceuticals, and GenScript.
Clariant cuts ties with life sciences and contract manufacturing
Clariant has cut its ties with the life sciences industry and will
no longer offer custom manufacturing services in this arena after
the sale of the last piece of its Lifesciences division.
PerkinElmer buys imaging software specialist
PerkinElmer have continued to expand their cellular imaging
portfolio with the acquisition of software company Improvision.
Systems biology research needs more funding, now
Systems biology research, a groundbreaking approach to drug
development, is not being given the financial backing it deserves
by the UK government, according to a new report.
Life sciences salaries soar
Salaries in the US life sciences industry have soared this year to
reach $74,000 (€58,000) on average as more companies seek to
attract and retain top talent by offering competitive remuneration
packages, according to the Scientist's...
Bioinformatics outsourcing poised for growth
Outsourcing is expected to emerge as a definitive trend in the
bioinformatics industry, according to a new report by Frost &
Tripos launches improved data access software
Tripos has launched new software that allows scientists to access
and analyse chemical and biological data from a single integrated
desktop discovery environment
SurModics deal results in novel synthetic ECM
Surmodics has announced that as a result of a collaboration with
the Donaldson Company, the first of a collection of new synthetic
nanofibrillar cell culture surfaces have been produced that will
improve cell culture, cell-based bioassays...
Invitrogen broadens its biotech branches
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
Pall Corporation 1Q reveals 16pc sales rise
Filtration system Pall Corporation reported its first quarter
earnings which revealed earnings rose by 16 per cent, propelled by
growth in its industrial and biopharmaceuticals segments.
Industries sign up to cut animal testing
An affirmation that aims to replace the use of laboratory animals
in testing was agreed in Brussels by key industry sectors
representing the European chemical, pharmaceutical and
Knowledge-based economy ensures life sciences funding
Life sciences is to be given priority under a European Commission
(EU) framework, which focuses on creating a knowledge-based economy
to ensure increased funding for this industry.
Invitrogen buys into nanotechnology as R&D tool
Invitrogen has announced two additional acquisitions in the area of
nanotechnologcal tools for target and drug discovery, just as it
completes the earlier-announced purchase of Biosource
Sigma-Aldrich restructures research units
Sigma-Aldrich is reorganising its operating structure, although its
fine chemicals unit SAFC will be unaffected by the restructuring.
Teranode launches first for screening software
Teranode Corporation has launched new screening automation software
that claims to be the first ever solution to transform assay design
into assay automation - a tool that is to feature heavily for
screening laboratories with changing...
Online research library unveiled
EMBiology, an online resource launched this week, aims to become
the main research library for pharmaceutical and biotechnology
companies, reports Ahmed ElAmin.
Evident launch quantum dot world first
Evident Technologies has launched the world's first commercially
available non-heavy metal quantum dot (QD) reagents that are less
toxic to cells.
Genevac launches EZ-Bio
Genevac has launched a brand new evaporation system aimed at the
molecular biology market. The technology marks a significant
departure for the company as its products have been focussed on
drug discovery chemistry until now.
Dynex deal strengthens Magellan microplate market spot
Magellan Biosciences' expressed interest in the life science,
research and clinical diagnostics market turned to action after the
life sciences company confirmed the acquisition of Dynex